On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach for major depressive disorder pioneered by Nolan Williams, M.D…
Read More
Researchers have obtained encouraging results in an early test of an accelerated form of non-invasive brain stimulation to treat major depressive disorder.
Read More
